Specialized Hypertonic Compositions for Niche Environments

Publication ID: 24-11857567_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Hypertonic Compositions for Niche Environments,” Published Technical Disclosure No. 24-11857567_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857567_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,567.

Summary of the Inventive Concept

This inventive concept adapts hypertonic pharmaceutical compositions containing anti-platinum chemoprotectant agents for specific, narrow markets or unique operational environments, such as high-altitude, disaster relief, high-security, extreme weather conditions, and remote, off-grid settings.

Background and Problem Solved

The original patent provided hypertonic pharmaceutical compositions containing anti-platinum chemoprotectant agents for general use. However, these compositions may not be suitable for specific environments where additional challenges, such as extreme temperatures, high altitudes, or limited resources, are present. This inventive concept addresses these limitations by adapting the compositions for these niche environments.

Detailed Description of the Inventive Concept

The new claims describe hypertonic pharmaceutical compositions containing anti-platinum chemoprotectant agents, tailored for specific environments. For high-altitude environments, the compositions have a calculated osmolarity of at least 1,500 mOsm/L. For disaster relief settings, the compositions are packaged in portable, waterproof containers. In high-security environments, the compositions are formulated to withstand temperatures above 100°F. For extreme weather conditions, the compositions are packaged in weather-resistant containers. In remote, off-grid settings, the compositions are formulated to be stable at room temperature for at least 6 months.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original compositions, making them suitable for specific environments. The inventive step lies in the tailored design of the compositions to address the unique challenges of each environment, which is not obvious from the original patent.

Alternative Embodiments and Variations

Other embodiments of this inventive concept could include adaptations for space exploration, underwater operations, or extreme humidity environments. Additionally, the compositions could be formulated for use in veterinary medicine or for protecting hearing in individuals with pre-existing hearing loss.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of oncology and otolaryngology. The adapted compositions could be marketed to healthcare providers, emergency responders, and military organizations operating in challenging environments.

Field of Art

Pharmaceutical formulations, specifically hypertonic compositions for chemoprotection and hearing loss prevention, requiring expertise in pharmaceutical chemistry, drug delivery systems, and medical applications

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical chemist or formulation scientist with advanced degree, experience in drug delivery, knowledge of osmolarity manipulation, stability testing, and environmental adaptation of pharmaceutical compositions

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's hypertonic pharmaceutical compositions could be readily adapted for specific environmental conditions by modifying osmolarity, packaging, and stability parameters. The core technical principles of anti-platinum chemoprotection remain consistent across the disclosed variations. The PTD represents predictable extensions of known pharmaceutical formulation techniques applied to a well-understood therapeutic approach.

Obvious Combinations & Variations

Source Patent Element
Hypertonic pharmaceutical composition with 3,000-7,000 mOsm/L osmolarity
PTD Variation
Adjusting osmolarity range for specific environments (1,500-3,500 mOsm/L)
Obviousness Reasoning
Osmolarity modification is a routine design choice for pharmaceutical formulations, with predictable results in drug delivery efficacy
Source Patent Element
Anti-platinum chemoprotectant agents like sodium thiosulfate
PTD Variation
Packaging adaptations for disaster relief, high-security, and extreme environments
Obviousness Reasoning
Container and packaging modifications are standard pharmaceutical engineering techniques for extending drug utility across different use scenarios
Source Patent Element
Gelling agents including hyaluronan and polyethylene glycol
PTD Variation
Temperature and stability modifications for room temperature storage and high-temperature resistance
Obviousness Reasoning
Formulation stability is a predictable optimization process using known polymer and excipient technologies
Source Patent Element
Pharmaceutical composition for preventing hearing loss
PTD Variation
Targeted adaptations for high-altitude, remote, and specialized medical environments
Obviousness Reasoning
Extending therapeutic applications to specific use cases represents a standard approach in pharmaceutical product development
Source Patent Element
Chemoprotectant composition with defined osmolarity
PTD Variation
Alternative embodiments for veterinary medicine and space exploration applications
Obviousness Reasoning
Cross-domain application of pharmaceutical technologies is a predictable innovation strategy for skilled practitioners
35 U.S.C. § 103 Summary: Based on US Patent 11857567, the present published technical disclosure demonstrates that the claimed variations in hypertonic pharmaceutical compositions represent obvious extensions of the prior art, employing routine pharmaceutical engineering techniques to adapt anti-platinum chemoprotectant formulations for specialized environmental conditions. A person having ordinary skill in pharmaceutical formulation would find the disclosed variations to be predictable modifications within the established technological framework of the source patent.

Original Patent Information

Patent NumberUS 11,857,567
TitleHypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
Assignee(s)Decibel Therapeutics, Inc.